The commercialization of transglutaminase
The aim of the projectThe overall objective of the TRANSCOM and TRANSPATH FP7 projects is: to establish the molecular nature of the role of the multifunctional enzymes transglutaminases in the pathogenesis of diseases which are known to involve their cross-linking activity, with a view to developing novel diagnostic assays, specific inhibitors and new therapeutic approaches. This will be achieved by the coordinated efforts of the recognised world experts in their respective fields. The project will facilitate the exchange of knowledge and technology between 3 leading European research teams in transglutaminases and 4 SMEs involved in the invention, development and production of diagnostic kits and treatments for health problems related to the activity of transglutaminases. Our ambitions for this project are: (1) increase the capabilities of highly skilled researchers for biotechnology industry and academia, and (2) have a major impact at European level
Scientific and Technology Objectives:
Project partners
Knowledge Transfer Objectives:
These focus on the transfer and use of skills and knowledge primarily between sectors but also between disciplines.
To meet these objectives work will be undertaken by staff on 20 secondments, six will involve staff moving from SMEs to academia and 14 will involve academic workers seconded to industry. Four new fellows will be recruited to bring additional skills and capability to the partnership. Contact
Gábor Zahuczky |
Contacts
|